Jonathan DuBois

Company: Biogen

Job title: Principal Scientist, Quantitative Imaging

Seminars:

Mapping Tau PET Tracers to Correlate with Cognitive Decline in Different Patient Cohorts for a More Biologically Driven Staging of Alzheimer’s Disease & Other Neurological Diseases 10:00 am

Exploring plasma p217+tau to show promise for separating either intermediate/advanced stage AD from lower stage AD to provide prognostic information and inform better selection for trials and disease modifying therapies Employing biological PET stages recommended by NIA-AA revised criteria to show disease progression with plasma p217+tau as an incremental stepwise trend capable of determining population-specific…Read more

day: Conference Day Two